kainic acid has been researched along with Central Nervous System Viral Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dawson, TM; Dike, S; Fannjiang, Y; Griffin, DE; Hardwick, JM; Huganir, RL; Jonas, EA; Kaczmarek, LK; Kerr, DA; Kim, CH; Larsen, T; Lindsten, T; Mandir, AS; Mito, T; Sappington, AL; Thompson, CB; Traystman, RJ; Zou, S | 1 |
1 other study(ies) available for kainic acid and Central Nervous System Viral Diseases
Article | Year |
---|---|
BAK alters neuronal excitability and can switch from anti- to pro-death function during postnatal development.
Topics: Age Factors; Animals; Animals, Newborn; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; Central Nervous System; Central Nervous System Diseases; Central Nervous System Viral Diseases; Disease Models, Animal; Epilepsy; Excitatory Postsynaptic Potentials; Genetic Vectors; Hippocampus; Kainic Acid; Male; Membrane Proteins; Mice; Mice, Knockout; Neurodegenerative Diseases; Neurons; Neurotoxins; Protein Structure, Tertiary; Sindbis Virus; Stroke; Synaptic Transmission | 2003 |